differences in semaglutide and tirzepatide Comparative safety side effects of and tirzepatide: Implications for clinical decision-making obesity management Tirzepatide vs. Ozempic: Comparing Diabetes

Built for the Move Weve prioritized portability with a compact 17x10x5cm footprint and a reinforced integrated hand strap

CDER Director George Tidmarsh (Credit: FDA via YouTube) In a first, FDA calls out Hims and other telehealth companies for GLP-1 advertising The FDA issued warning letters to telehealth companies for making false or misleading claims about compounded GLP-1 obesity drugs

For instance, blood sugar levels may run higher than they did while on the medication, which may result in higher-than usual readings for some individuals

Easy to layer into existing appointment time

Given the clear relationship between IGF-1 and aging, we reasoned that IGF-1R mAbs could provide a translational tool to mimic the beneficial effects reported by reduced signaling in this pathway

The goal is to help patients build mindful eating habits, understand proper portion sizes, and reduce impulsive eatingwhile also establishing consistent movement and a nutritious diet